ES2046229T3 - Composicion antiulcerosa. - Google Patents

Composicion antiulcerosa.

Info

Publication number
ES2046229T3
ES2046229T3 ES198888106655T ES88106655T ES2046229T3 ES 2046229 T3 ES2046229 T3 ES 2046229T3 ES 198888106655 T ES198888106655 T ES 198888106655T ES 88106655 T ES88106655 T ES 88106655T ES 2046229 T3 ES2046229 T3 ES 2046229T3
Authority
ES
Spain
Prior art keywords
composition
ulcer composition
ulcer
chem
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198888106655T
Other languages
English (en)
Spanish (es)
Inventor
Kazumi Ogata
Takahiro Ogawa
Takahiro Sakaue
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Original Assignee
Senju Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co Ltd filed Critical Senju Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2046229T3 publication Critical patent/ES2046229T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/665Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES198888106655T 1987-04-28 1988-04-26 Composicion antiulcerosa. Expired - Lifetime ES2046229T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62106077A JP2526059B2 (ja) 1987-04-28 1987-04-28 抗潰瘍剤

Publications (1)

Publication Number Publication Date
ES2046229T3 true ES2046229T3 (es) 1994-02-01

Family

ID=14424526

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198888106655T Expired - Lifetime ES2046229T3 (es) 1987-04-28 1988-04-26 Composicion antiulcerosa.

Country Status (8)

Country Link
US (1) US4888329A (ja)
EP (1) EP0288969B1 (ja)
JP (1) JP2526059B2 (ja)
AT (1) ATE86860T1 (ja)
CA (1) CA1310271C (ja)
DE (1) DE3879258T2 (ja)
ES (1) ES2046229T3 (ja)
GR (1) GR3007460T3 (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0781138B2 (ja) * 1986-12-02 1995-08-30 株式会社資生堂 抗酸化剤
PH25859A (en) * 1988-01-11 1991-12-02 Takeda Chemical Industries Ltd Composition for treatment of ischemic disorder
JP2736794B2 (ja) * 1988-12-26 1998-04-02 千寿製薬株式会社 歯垢生成防止剤
FR2657526B1 (fr) * 1990-01-31 1994-10-28 Lvmh Rech Utilisation d'un phosphate d'alpha-tocopherol, ou de l'un de ses derives, pour la preparation de compositions cosmetiques, dermatologiques, ou pharmaceutiques; compositions ainsi obtenues.
FR2679904A1 (fr) 1991-08-01 1993-02-05 Lvmh Rech Utilisation d'un phosphate de tocopherol, ou de l'un de ses derives, pour la preparation de compositions cosmetiques, ou pharmaceutiques et compositions ainsi obtenues.
TW252918B (ja) * 1993-03-31 1995-08-01 Senju Pharma Co
TW254852B (ja) * 1993-12-02 1995-08-21 Senju Pharma Co
JPH07196516A (ja) * 1993-12-29 1995-08-01 Senju Pharmaceut Co Ltd 痔疾患治療剤
JPH07330501A (ja) 1994-06-14 1995-12-19 Senju Pharmaceut Co Ltd 肝保存剤および肝保存方法
CA2152693A1 (en) * 1994-08-05 1996-02-06 Kazumi Ogata Therapeutic composition for pancreatitis
CA2179940A1 (en) * 1995-07-18 1997-01-19 Kazumi Ogata Antiallergic composition comprising a phosphoric diester compound
JPH09194375A (ja) * 1996-01-17 1997-07-29 Senju Pharmaceut Co Ltd 免疫抑制作用増強剤
WO1999039716A1 (fr) * 1998-02-03 1999-08-12 Senju Pharmaceutical Co., Ltd. Substances preventives et medicaments destines aux maladies neurodegeneratives
US6277834B1 (en) 1998-06-19 2001-08-21 Senju Pharmaceutical Co. Ltd. Agents for relieving side effects of adrenal cortex hormone

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59219295A (ja) * 1983-05-30 1984-12-10 Senjiyu Seiyaku Kk リン酸ジエステルまたはその塩およびそれらの製造法
JPS62205091A (ja) * 1986-03-04 1987-09-09 Senjiyu Seiyaku Kk 新規なリン酸ジエステルならびにその塩、その製造法およびそれを含有する製剤

Also Published As

Publication number Publication date
EP0288969A2 (en) 1988-11-02
JP2526059B2 (ja) 1996-08-21
DE3879258T2 (de) 1993-07-22
CA1310271C (en) 1992-11-17
DE3879258D1 (de) 1993-04-22
EP0288969B1 (en) 1993-03-17
JPS63270626A (ja) 1988-11-08
EP0288969A3 (en) 1990-05-23
ATE86860T1 (de) 1993-04-15
GR3007460T3 (ja) 1993-07-30
US4888329A (en) 1989-12-19

Similar Documents

Publication Publication Date Title
FI862757A (fi) Pyridonkarbonsyraderivat och foerfarande foer framstaellning av dessa.
NO173867C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzamider
ES2046229T3 (es) Composicion antiulcerosa.
DE3772015D1 (de) Chinolinverbindung.
ATE45354T1 (de) Chinoloncarbonsaeurederivate.
DE3665711D1 (de) Novel guanidinomethylbenzoic acid derivatives
ES2038710T3 (es) Un procedimiento de preparacion de un derivado de benzoxazina y su utilizacion.
ATE83377T1 (de) Antianaerobe naphthyridinverbindungen.
DK0413278T3 (da) Anvendelse af xanthinderivater mod mavesår
DE3766863D1 (de) Fungizide.
ES2040223T3 (es) Derivados de la tiadiazolilacetamida, procedimiento para su fabricacion y su utilizacion.
ES8307812A1 (es) Un procedimiento para la preparacion de nuevos amidin derivados del acido clavulawilo.
AU8292787A (en) Fluorine-containing macrolide compounds and their use
ATE36536T1 (de) Phosphoroimidate.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 288969

Country of ref document: ES